Pages
-
Recent Blog Posts
Themes
ABC ACCC advertisments AHPRA AMHC AMI Blackmores CHC Chiropractic Board Code authorisation Complaint Resolution Panel consumers CRP Dr Jacqui Forrester Dr Tom Goyer FSANZ FSM Geoff Jowett Gerald Quigley HAIAP Health Practitioner Regulation National Law Act health professionals homeopathic medicines La Trobe University Medicines Australia MMD Review Monash University MWI Pharmacare Laboratories promotion Regulation Reform Regulatory Reform self-regulation Senate Community Affairs Legislation Committee Souvenaid Swisse Swisse Vitamins TGA TGACC Therapeutic Goods Act Therapeutic Goods Advertising Code Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017 Transparency U3A UndoitArchives
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- January 2015
- December 2014
- November 2014
- October 2014
- July 2014
- March 2014
- February 2014
- January 2014
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- August 2012
- July 2012
- May 2012
- April 2012
- March 2012
- June 2011
Category Archives: Pharmaceutical Promotion
Therapeutic Goods Advertising Consultative Committee, First meeting today
This committee has replaced the now abolished Therapeutic Goods Advertising Code Council. Choice (Australian Consumers’ Association) was a member of previous Code Council (and Complaint Resolution Panel). No doubt the failure of the TGA to invite Choice to this new … Continue reading
Natural health products the largest selling OTC medicines in 2015–16
From Australia’s health 2018 (full publication; 4 June 2018 edition); see also: http://www.abc.net.au/news/2018-10-03/chart-of-the-day-natural-therapies-vitamins/10328514 These results reflect the large amount of money spent on marketing these products (Swisse $50 million per annum) and the failure of the regulator (the TGA) to act on … Continue reading
APHC 2018 Contested Policy: Complementary Medicines and Advertising Reform
Chair: Ken Harvey Speakers: John Skerritt – Overview of MMD recommendations Alanna Rottler – Pre-approval of certain advertisements to cease Jon Wardle – Permitted indications to replace ARTG ‘free text’ Alanna Rottler – A new listing pathway (and an optional … Continue reading
Posted in Complementary medicine, Education, Medicine policy, Pharmaceutical Promotion
Tagged Advertising complaint system, Alanna Rottler, APHC 2018, AUST L, AUST-L(A), AUST-R, Blackmores, Complementary Medicines and Advertising Reform, John Skerritt, Jon Wardle, Mal Vickers, new listing pathway, Permitted indication, PHAA, Pharmacare Laboratories, Policy analysis, Pre-approval of advertisements, Review of low-risk product, Swisse, Terry Slevin, TGA. MMD Review
Leave a comment
TGA advertising system concerns: response from TGA
For background see: http://www.medreach.com.au/?p=2778 From: SKERRITT, John <John.Skerritt@health.gov.au> Sent: Tuesday, 18 September 2018 21:13 To: ken.harvey@medreach.com.au Cc: MCLAY, Nicole <Nicole.McLay@health.gov.au>; FRANCIS, Jenny <Jenny.Francis@health.gov.au>; SKERRITT, John <John.Skerritt@health.gov.au> Subject: RE: Letter from ACCC – TGA advertising concerns [SEC=UNCLASSIFIED] Dear Dr Harvey Thank you … Continue reading
TGA advertising complaint system concerns: response from Minister Hunt and Ombudsman
Minister Hunt (or more likely the TGA) has now responded to my letter that expressed concerns about the new TGA advertising complaint system. The Minister confirms that the TGA’s advertising complaint system was designed to be non-transparent for low priority … Continue reading
Complaint to Commonwealth Ombudsman – TGA advertising complaint system
From 1 July 2018, the Therapeutic Goods Administration took over the complaint system for the advertising therapeutic goods to the public from the Complaint Resolution Panel (CRP). Many concerns about this TGA takeover were submitted in consultation submissions. They were … Continue reading
TGA new complaint system: compliance notices ineffective
Two outcomes (of 16) TGA complaints have now been received. AC-E7JS15BB/2018, submitted 3/8/18, Brand Developers Australia Pty Ltd – Pain Erazor https://www.youtube.com/watch?v=ye6s7qB-4Gc&feature=youtu.be “Pain Erazor” (ATG no: 276939) won a 2017 Choice “Shonky” award, was the subject of … Continue reading
Launch of TGA Advertising Hub – Initial experience of submitting complaints
The TGA Advertising hub has noted: “We are experiencing intermittent IT issues that are impacting this form. If you experience an error lodging a complaint, please try again later. We are working to fix this issue as a matter of … Continue reading
Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion
Tagged A Menarini Australia Pty Ltd, Au Remedial, Bioglan, BioRevive® Hydrodol® Hangover Relief Products, Body Armour Pty Ltd, Brand Developers., Clever Health, complaint outcomes, D & X Pty Ltd, Detox foot pads, Ear candles, Export Corporation Australia Pty Ltd, Hangover Relief, Healthy Care, Hey! King Premium Hangover Relief, Homeopathic products, Hydroxycut Hardcore Elite, New Life Health Products 14 Day Smart Cleanse, Pain Erazor, Pharmacare Laboratories, Phoenix Pharmaceuticals Rapid Recovery Hangover Relief, PINPOINT Bright Brains (Bacopa Monnieri), Plus Daily Ltd, Pretorius, Recoverthol, Regulatory Reform, Rejoove, Seremind, TGA, TGA Advertising Hub, TGA new complaint system, Therapeutic Goods Advertising Code, Transparency, Welda
Leave a comment
TGA’s new complaint system fails the Ease-a-cold test; Outcomes of Advertising Complaints Investigations Specification 2018 enacted
Stimulated by an article in today’s “The Conversation” on Pharmacare Laboratories Ease-a-Cold (below), I decided to try the TGA’s new complaint system.As I mentioned in a comment on this article, this product has been the subject of a previous article … Continue reading
Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion
Tagged Ease-a-Cold, Pharmacare Laboratories, Regulatory Reform, TGA, TGA Complaint system, Therapeutic Goods Advertising Code, Therapeutic Goods Information (Outcomes of Advertising Complaints Investigations) Specification 2018
Leave a comment
TGA Advertising Portal and Complaint System now live; Industry embrace permissible indications
See: https://www.tga.gov.au/advertising-hub and: https://ajp.com.au/news/tga-explains-new-advertising-landscape/ However, there are still concerns about the transparency of the new system and my colleagues and I are holding off submitting complaints until we know: The outcome of the TGA Consultation: Complaints handling – Advertising therapeutic goods to … Continue reading